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Abstract
This paper provides a first glimpse of the use of business intelligence (BI) into healthcare and wellbeing.
There are new and exciting possibilities to use BI business intelligence in this area. With the help of big
data technologies, there is interest from public and private organisations, academic researchers, health
professionals and technology vendors to implement as well as evaluate the impact of BI. A potentially
important issue is that of the openness of the data for BI which could have repercussions for different
actors. . In relation to the ‘openness’ of the data being managed, we identify a number of challenges.
Discussion of these issues should inform future research and practice in BI in this area and elsewhere.
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1.0

Introduction

The emergence of Business Intelligence (BI) and its use in human healthcare and
wellbeing contexts creates opportunities to extract and use relevant knowledge obtained
from analysing large volumes of data. Generally speaking, BI is a set of processes
supported by technologies that enable people to discover patterns that are ‘hidden’ in the
data to the human eye in order to inform decisions. Technologies to process and analyse
data include transactional databases, data warehouses, online analytical processing
(OLAP) and data mining tools and techniques (Laudon and Laudon, 2013; Chen et al,
2012). With BI, better, specialised and cost effective services and treatments can also
yield benefits for payers and the public in general.

With new technologies and practices of big data in these contexts, there is interest from
different stakeholders (public and private organisations, health professionals, technology
vendors and patients) to better understand the role that BI could play and more
specifically the issues related to the openness of data.

The purpose of this paper is to

provide a brief overview as well as an initial evaluation of what would happen if data
generated from BI would be made open to different stakeholders and more specifically to
prospective and current healthcare and well being users. This would require addressing a
number of issues in both the design as well as implementation of BI. In the next section
an overview of BI in healthcare is presented.

2.0

What we know so far: Business Intelligence in Healthcare and
Wellbeing

Business intelligence or BI in healthcare is relatively a young area of research and
practice. There are different technologies that have been applied to healthcare problems
ranging from telemedicine to detailed analysis of human tissue for detection of illnesses
(i.e. cancer) (Laudon and Laudon, 2013; Chen et al, 2012).

Wellbeing is a

complementary area to healthcare regarding health prevention and is taking shape in the
form of early detection of diseases as well as support for quality of life improvement
personal programmes (Stewart and Ware, 1992)

In trying to understand how new technologies of big data for BI as well as government
policies to ‘open’ healthcare data, a future trend is that of conceptualising BI as part of an
ecosystem of data in which different actors, their values and interests intersect and
mutually co-evolve and use latest technologies to both generate as well as access data
(Chen et al, 2012; Harrison et al. 2012). The following diagram follows Mettler and
Virmalund (2009)’s framework and provides an overview of BI in the healthcare context.
This framework can be discussed and enriched with actors as new technologies and
policies affecting both healthcare/wellbeing contexts are formulated and implemented by
governments.

Figure 1.

A framework for Business Intelligence in Healthcare (and Wellbeing) (from Mettler
and Virmalund, 2009).

In the diagram, it can be seen that the main components include processes, actors,
information technologies and data. Of particular importance is the distinction between
information and data. Data are sets of raw measurements and facts which are collected
from different sectors and from different actors involved (Stewart and Ware, 1992; Scott,
2012). In turn information is the representation of those facts and measurements through
analysed reports or visualised graphs. Data are normally machine readable facts and the
result of processing them will generate the information that is used by human actors in
the system. The main sources of data include:



Clinical

data

sources,

which

are

required

to

provide

and

deliver

healthcare/wellbeing services and products to patients. These are all medical data
collected from patient records, laboratory results, treatment process and follow
ups. With current policies in countries like the UK, billions of personal health
records are being created, made anonymous and sold to third parties (i.e. market
research companies) (Sunday Times, 2014).


Administrative data, which are needed to run the healthcare business and
organisation. These data are business data from organisational actors’ personnel
data, financial data and back office requirements.



External data that includes external providers’ clinical or administrative data such
as statistical data, medical reports or insurance forms.

As the data comes from different sources and is used in various ways, in BI for healthcare
what is also relevant to note is the diversity of actors involved. Unlike other industries,
there are clinical and administrative actors. Each of these needs different access and
reporting mechanisms. Furthermore BI solutions could –in principle offer data to a
variety of users (actors) with diverse needs (e.g. patients, insurance companies,
governmental authorities, doctors). These can be seen as customers whose behaviour and
expectations differ from one to the other. Considering this diversity, BI solutions should
also include some soft metrics to include patient’s feelings and choices, as well as hard
metrics that are required to monitor and evaluate the business performance of
organisational actors (Avison and Young, 2007)

3.0

Meaningful use

Successful BI implementation in healthcare can be expensive and difficult. Achieving
desired benefits is a slow process until benefits become apparent and perceived by
different actors. A managerial and linear perspective on BI would suggest that its
implementation should be gradual, in other words ‘lineally oriented’, and in each stage
there should be clear objectives to achieve. In countries like the US, there are different

legislations to clarify different stages and objectives for each one (Blumenthal and
Tavenner, 2010). These are:


Creating and gathering information including the entry of basic data such as
patients’ vital signs, demographics, up-to-date list of problems and current
diagnoses, current and active medications, allergies, tobacco status and weight
screening (Blumenthal and Tavenner, 2010).



Use of BI applications to ‘discover patterns’ and hence reveal the true potential of
these systems to advance quality, efficiency and safety of care. With patterns,
providers could have better access to patients’ information for a better decision
making as well as avoiding preventable errors (Blumenthal and Tavenner, 2010).
For instance, there are BI examples that have supported large case-control of
pancreatic cancer risks. Using BI, researchers have analylsed electronic records
for symptomatic patients in primary care to identify and quantify the features of
pancreatice cancer. (Stapley S., et al., 2012). Another example in this area is the
discovery of patterns of cancer risk in patients with different hip replacements
bearing surface types. The data that was used was the US General Practice
Research Database which is part of the Clinical Practice Research Datalink
(CPRD) and which collects computerised medical records from general
practitioners (Lalmohamed A., et al., 2013).



Patient empowerment.

This is achieved by enabling patients to access their

complete health records. BI systems also improve the personal healthcare that
patients receive by performing different services such as: reminders for checkups, patient-specific health education, prescription checks, integrated clinical
laboratory results as well as supporting patients’ transitions between care settings
or personnel (Blumenthal and Tavenner, 2010).

All these stages involve the generation of quality reports. These reports could identify
and assess health providers’ performance and decision making, control medicine
prescriptions as well as patients’ satisfaction. These reports may eventually become
public (Blumenthal and Tavenner, 2010).

4.0

Opening the data from BI

Current government policies in countries like the US and the UK encourage the opening
up of healthcare data (Harrison et al, 2012). The idea is to generate an ecosystem in
which data circulates through different actors and is recycled to fulfil a number of goals.
There can be new technological innovations in the form of for instance software
applications that use the data for the benefit of patients. In addition, patients can exert
better accountability over their healthcare providers and use data to provide evidence and
argue their case against government (Harrison et al, 2012; Gurstein, 2011). Finally,
governments can assess the impact of their health policies in several areas as well as the
quality of services provided by third parties.

The opening of data follows a general trend to open government to public accountability
and facilitate citizens’ engagement with new technologies like social media (Lee and
Kwak, 2012). Within this trend, and similar to BI, the idea is to follow a linear process
of development. Lee and Kwak (2012) show this process when they set out the following
stages for open government:

initial conditions (availability of data, Level 1), data

transparency (making data accessible, Level 2), open participation (encouraging citizens’
access, Level 3), open collaboration (data partnerships Level 4), and ubiquitous
engagement (use of social media, Level 5).
BI ‘3.0’ (including big data technologies as stated by Chen et al 2012) can follow a
similar pattern and transform healthcare and wellbeing from being disease control based
to patient centred. With the help of new applications that make use of sensor, mobile and
social media technologies, more sophisticated health monitoring and analysis, health text
analytics, health ontology definitions, patient network analysis as well as economic
analysis can be performed (Chen et al, 2012). However, when it comes to ‘opening up’
the BI data of such analyses to users (patients), there are a number of issues which
policies and initiatives will need to consider. The following issues are proposed to be
considered in BI in health care/wellbeing initiatives as ‘open’ data:



Data neutrality and contextualisation.

According to Johnson (2013), “it is

exceptionally easy for data scientists and users to accept current data practices and
outcomes as natural or inevitable, and to make data use the only moral question of
interest” (pp.2).

Even the opening of people’s data is not going to benefit them

unless the assumptions and worldviews that led to the construction of such data
are critically reviewed and discussed.

This is the case for instance of

marginalised communities or minorities whose data does not tell much about them
(there is not much data that they were able to fill) (Gurstein, 2011; Johnson, 2013)
and therefore any future initiative is not going to be of much help to them.


Future use of data. This is one of the biggest concerns posed by the public.
Although people are often promised that their own personal data is to be made
anonymous and is to be managed by ‘bona fide’ experts (business intelligence
analysts, health professionals and scientists among others), experience in
countries like the US with the human genome data shows that once data is
collected, aggregated and analysed, it can be sold to third parties which can then
use it to produce commercial solutions (i.e. drugs). The case of the NHS in the
UK (Sunday Times, 2014) shows that governments have already established
bilateral partnerships which go contrary to the philosophy of open data, in which
governments provide some guiding intentions for the use of data but then
facilitate collaboration, co-operation and the achievement of public value through
the work of different actors in open data initiatives (Harrison et al, 2012).
Patients who want to opt out from this initiative have to fill forms and check on
the process. An espoused rationale for building big data infrastructures based on
citizens’ trust can be eroded if data is used for commercial purposes (Dickenson,
2014; Sunday Times, 2014). This could affect negatively the future engagement
of citizens in healthcare/wellbeing policies and initiatives.



Ownership of data. The future management of large volumes of data requires
important investments in resources as well as decisions on who is to own its
preservation (Lynch, 2008). In countries like the UK, Universities seem to be

taking the lead in collecting and storing online data (Pritchard and Whiting,
2012). In other parts of the world, well-being BI initiatives are emerging. A
long-term strategy to store and making data available to different actors should be
defined alongside the design of BI initiatives.


Accuracy of data.

The experience of using human genome data shows that

analysis of big data can produce different results. Analysis techniques are still
unproven and increasingly being refined. If analysis data is available for direct
public consumption there could be different answers provided to them with the
risk of contradictory well-being decisions being made (Dickenson, 2014). In the
context of BI for healthcare and wellbeing, the distinction between data and
information is a key one if people are going to be provided with meaningful BI
information.


Transparency and accountability. The collection, gathering and analysis of data
can become a public source of transparency and accountability of healthcare and
wellbeing professionals.

Information provided by BI initiatives can put into

question the knowledge and expertise that is exhibited by these professionals, in
particular if the aim of their organisations show transparency to the public via
electronic data (Gabe et al. 2012). However, in achieving transparency and
accountability it is important to promote data literacy. Gurstein (2011) makes a
case for empowering the citizens rather than simply enabling them to access data.
In particular when data is being summarised, it loses its context, in other words it
loses its meaning and therefore meaning for citizens needs to be created. Data
literacy needs to be encouraged, and in doing so the role of intermediaries is
essential to both help citizens analyse the data as well as use it in a relevant
context of application.


Social media use for data collection. According to Lee and Kwak (2012), social
media technologies can be a supporting platform to facilitate citizens’
engagement. However, other actors from the BI ‘ecosystem’ (i.e. government)

could be gathering citizens’ data without citizens being fully informed or being
aware of it (Oboler et al, 2012). This is worrying, given that often citizens rely on
their governments to protect them from invasion to their privacy by commercial
actors. Open discussions about how data is to be used should inform future
development of BI initiatives.

These and other issues are interconnected and require a holistic system of enquiry to
address them, one which is critically constructive of the ecosystem one. Given their
social, ethical and technical nature, they also signal the importance of adopting a less
functionally oriented and linear approach in favour of a more ethical and human centred
perspective to BI in the healthcare and wellbeing contexts. If this is the case, it becomes
important to facilitate debate or dialogue about what / who should constitute relevant and
legitimate aims, actors and potential effects of BI initiatives, in particular in relation to
their potentially ‘open’ nature; the meaning of ‘open for what’ and ‘open to whom’
should be discussed. A possibility is to adopt a systems thinking approach to enable
dialogue, participative and consultative design and evaluation of BI initiatives. Intending
to take this further, future research stages will include studying further applications of BI
in these contexts as well as exploring systems thinking methods and approaches to
facilitate intervention and improvement of BI initiatives.
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